The filing confirms the Kira merger closed and the COO's equity grant is now public. Monitor for the stockholder vote on preferred stock conversion, which could significantly increase the common share count (up to ~5.6M shares from the preferred alone). The 48-month vesting schedule aligns management incentives with long-term performance.
Price Chart
Executive Summary
Matthew E. Ros filed an initial statement of beneficial ownership (Form 3) with the SEC, disclosing his position as Chief Operating Officer of Jasper Therapeutics and the securities he received in connection with the company's merger with Kira Pharmaceuticals on July 16, 2026. The filing details the conversion of his Kira stock options into 103,204 options for Jasper voting common stock and 92,278 options for non-voting convertible preferred stock, which can convert into common stock at a 61:1 ratio upon stockholder approval. This is a routine post-merger insider filing that confirms the closing of the Kira acquisition and the COO's equity stake, but provides no new financial data or operational updates.
Key Facts
- Matthew E. Ros filed Form 3 as Chief Operating Officer of Jasper Therapeutics, effective July 16, 2026.
- The filing is tied to the merger with Kira Pharmaceuticals, which closed on July 16, 2026.
- Ros received 103,204 options to purchase voting common stock at $0.01 per share and 92,278 options to purchase non-voting convertible preferred stock at $0.61 per share.
- The preferred stock options can convert into 61 shares of voting common stock each upon stockholder approval, subject to a 4.9%-19.9% ownership cap.
- The options vest monthly over 48 months starting June 7, 2026, contingent on continued service.
Financial Impact
No financial figures disclosed beyond option strike prices ($0.01 and $0.61) and share counts (103,204 common, 92,278 preferred). The merger consideration structure is disclosed but no dollar values for the deal or the options are provided.
Risk Factors
- Potential dilution from conversion of preferred stock into common shares upon stockholder approval.
- No financial or operational data in the filing to assess company performance or merger synergies.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (JSPR) — Batch item 1 | 0001213900-26-080523 |
| Document: 0001213900-26-080523-index-headers.html | 0001213900-26-080523 |
| Document: 0001213900-26-080523-index.html | 0001213900-26-080523 |
| Document: 0001213900-26-080523.txt | 0001213900-26-080523 |
| 3 Filing (JSPR) — Batch item 5 | 0001213900-26-080523 |
| Document: 0001213900-26-080523-index-headers.html | 0001213900-26-080523 |
| Document: 0001213900-26-080523-index.html | 0001213900-26-080523 |
| Document: 0001213900-26-080523.txt | 0001213900-26-080523 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | SC TO-I/A | $0.5100 | awaiting T+5 | — | $0.5054 (−0.90%) |
Oct 20, 2026 6d ago | DEF 14A | $0.4999 | awaiting T+5 | — | $0.5054 (+1.10%) |
Oct 15, 2026 11d ago | 8-K | $0.5321 $0.4956 | ▼ −6.86% | ▼ −5.85% | $0.5054 (−5.02%) |
Oct 15, 2026 11d ago | Press Release | $0.5320 $0.4960 | ▲ +6.77% | ▲ +5.75% | $0.5054 (+5.00%) |
Oct 14, 2026 11d ago | S-3 | $0.5321 $0.4956 | ▲ +6.86% | ▲ +5.85% | $0.5054 (+5.02%) |
Oct 7, 2026 19d ago | 8-K | $0.5697 $0.5010 | ▼ −12.06% | ▼ −11.08% | $0.5054 (−11.29%) |
Oct 7, 2026 19d ago | SC TO-I | $0.5697 $0.5010 | ▼ −12.06% | ▼ −11.08% | $0.5054 (−11.29%) |
Sep 24, 2026 4w ago | 25-NSE | $0.6091 $0.5652 | ▲ +7.21% | ▲ +6.99% | $0.5054 (+17.03%) |
Aug 14, 2026 10w ago | Press Release | $0.7901 $0.7160 | ▼ −9.38% | ▼ −8.01% | $0.5054 (−36.03%) |
Jul 31, 2026 12w ago | 8-K | $0.6300 $0.7095 | ▲ +12.62% | ▲ +9.11% | $0.5054 (−19.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers